Lirentelimab for severe and chronic forms of allergic conjunctivitis.
Anesi SD, Tauber J, Nguyen QD, Chang P, Berdy GJ, Lin CC, Chu DS, Levine HT, Fernandez AD, Roy N, Asbell PA, Kantor AM, Chang AT, Singh B, Youngblood BA, Jeng BH, Jhanji V, Rasmussen HS, Foster CS.
Anesi SD, et al. Among authors: kantor am.
J Allergy Clin Immunol. 2022 Sep;150(3):631-639. doi: 10.1016/j.jaci.2022.03.021. Epub 2022 Apr 4.
J Allergy Clin Immunol. 2022.
PMID: 35390403
Free article.
Clinical Trial.